GENETIC TESTING

Inside the Diagnostics Industry: New Government BRCA Test Guidelines Are a Mixed Bag for Genetic Testing Labs

The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment, genetic counseling and testing in the Aug. 20 issue of the Journal of the … [Read more...]

INSIDE THE INDUSTRY

Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test

Few of the newfangled consumer genetic testing products have had greater commercial success and visibility than Exact Science's Cologuard colorectal cancer screening test. But a troubling new … [Read more...]

TESTING TRENDS

Search Intensifies for Markers for Prosthetic Joint Infection

Nearly one million total hip arthroplasties and total knee arthroplasties are performed in the United States each year, a number that is expected to continue to increase for decades given the aging of … [Read more...]

PUBLIC HEALTH

Partnerships, IT Solutions Improve Infectious Disease Diagnostic Stewardship

Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity. While unnecessary or inappropriate testing can lead … [Read more...]

INSIDE THE DIAGNOSTICS INDUSTRY

The Practice of Early Gestational Diabetes Screening Evaluated

The U.S. Centers for Disease Control and Prevention estimates that each year, gestational diabetes mellitus (GDM) affects between 2 percent and 10 percent of pregnancies. Experts say there has been a … [Read more...]

PRECISION MEDICINE

Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies

Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last 10 years. While whole-exome sequencing (WES) has shown utility … [Read more...]

TESTING STRATEGY

Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People

Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic. Previous screening guidelines have focused on reaching the estimated 2.7 million persons … [Read more...]

PAMA

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]

GENETIC TESTING

Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine, but adoption of PGx testing has not lived up to its potential and remains in an … [Read more...]

PRECISION MEDICINE

New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by Concert Genetics … [Read more...]


(-00000g2)